These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Some clinical and therapeutical aspects of porphyries caused by barbiturates. Vecchi C; Belisario C Panminerva Med; 1966 Sep; 8(9):329-32. PubMed ID: 5925928 [No Abstract] [Full Text] [Related]
3. Anesthesia and the porphyrias. Larter RA AANA J; 1978 Jun; 46(3):271-81. PubMed ID: 716818 [TBL] [Abstract][Full Text] [Related]
4. Hexachlorobenzene and 2, 4, 5, 2; 4; 5'-hexachlorobiphenyl - a comparison of their distribution, biotransformation and porphyrinogenic action in female rats. Koss G; Seubert S; Seubert A; Herbert M; Koransky W; Ippen H Dev Toxicol Environ Sci; 1980; 8():517-20. PubMed ID: 6796376 [No Abstract] [Full Text] [Related]
5. The porphyrias: the royal purple? Dean G J R Coll Physicians Lond; 1970 Oct; 5(1):47-61. PubMed ID: 4950459 [No Abstract] [Full Text] [Related]
6. [Does the hexachlor-cyclohexan containing scabicide, the Jacutin, possess porphyrinogenic properties?]. Berkó G; Szilágyi I Z Hautkr; 1975 Dec; 50(24):999-1002. PubMed ID: 55007 [No Abstract] [Full Text] [Related]
8. [Experimental porphyria model with hexachlorocyclohexane]. Simon N; Siklósi C Z Hautkr; 1974 Jun; 49(11):497-504. PubMed ID: 4138435 [No Abstract] [Full Text] [Related]
11. [Changes in porphyrin metabolism in porphyria induced in rats by hexachlorobenzene]. Enríquez de Salamanca R; Mas Andrés V; Catalán Beltrán T; Olmos Andrés A; Peña Payero ML; Molina Ferragut C; Chinarro Familiar S; Muñoz González JJ Actas Dermosifiliogr; 1981; 72(7-8):289-300. PubMed ID: 7331905 [No Abstract] [Full Text] [Related]
12. The inhibition of terminal oxidation by porphyrinogenic drugs. Cowger ML; Labbe RF Biochem Pharmacol; 1967 Nov; 16(11):2189-99. PubMed ID: 4169494 [No Abstract] [Full Text] [Related]
13. [The role of some chemical factors in the pathogenesis of late cutaneous porphyria]. Pankov BS Vestn Dermatol Venerol; 1968 Dec; 42(12):21-5. PubMed ID: 5737435 [No Abstract] [Full Text] [Related]
14. [Experimental porphyria induced with 2-allyloxy-3-methylbenzamide. II. Changes in porphyrin metabolism in the rat]. Mazza U; Battistini V; Amerio PL; Massaro AL; Prato V Boll Soc Ital Biol Sper; 1965 Sep; 41(18):1082-4. PubMed ID: 5878966 [No Abstract] [Full Text] [Related]
15. [Disorders of porphyrin metabolism and their clinical manifestations]. Popović K; Stanulović M Med Pregl; 1969; 22(3):181-6. PubMed ID: 5197864 [No Abstract] [Full Text] [Related]
16. The role of the kidneys in disorders of porphyrin metabolism during carcinogenesis induced with lead acetate. Zawirska B; Medraś K Arch Immunol Ther Exp (Warsz); 1972; 20(2):257-72. PubMed ID: 5024632 [No Abstract] [Full Text] [Related]
17. [Effect of sex hormones on porphyrin metabolism in model studies]. Simon N; Berkó G; Dobozy A Dermatol Monatsschr; 1973 Sep; 159(9):868-71. PubMed ID: 4770771 [No Abstract] [Full Text] [Related]
18. [Mixed or variegata porphyria. Familial study]. Stewart W; Lauret P; Lecroq C Bull Soc Fr Dermatol Syphiligr; 1970 Jul; 77(1):29-32. PubMed ID: 5430034 [No Abstract] [Full Text] [Related]